Skip to main content
Erschienen in: Wiener klinische Wochenschrift 7-8/2019

01.04.2019 | editorial

What is normal? A central question in the application of CMR mapping techniques

verfasst von: Andreas A. Kammerlander, MD, PhD, a.o. Univ. Prof. Dr. Julia Mascherbauer, MD

Erschienen in: Wiener klinische Wochenschrift | Ausgabe 7-8/2019

Einloggen, um Zugang zu erhalten

Excerpt

New techniques in cardiovascular imaging are rapidly evolving and unfold new pathways in clinical practice. In cardiovascular magnetic resonance imaging (CMR) T1-mapping has revolutionized the understanding of the myocardial extracellular space and its importance in a variety of cardiac disorders. …
Literatur
1.
Zurück zum Zitat Kammerlander AA, Duca F, Binder C, et al. Extracellular volume quantification by cardiac magnetic resonance imaging without hematocrit sampling: Ready for prime time? Wien Klin Wochenschr. 2018;130:190–6.CrossRef Kammerlander AA, Duca F, Binder C, et al. Extracellular volume quantification by cardiac magnetic resonance imaging without hematocrit sampling: Ready for prime time? Wien Klin Wochenschr. 2018;130:190–6.CrossRef
2.
Zurück zum Zitat aus dem Siepen F, Buss SJ, Messroghli D, et al. T1 mapping in dilated cardiomyopathy with cardiac magnetic resonance: quantification of diffuse myocardial fibrosis and comparison with endomyocardial biopsy. Eur Heart J Cardiovasc Imaging. 2015;16:210–6.CrossRef aus dem Siepen F, Buss SJ, Messroghli D, et al. T1 mapping in dilated cardiomyopathy with cardiac magnetic resonance: quantification of diffuse myocardial fibrosis and comparison with endomyocardial biopsy. Eur Heart J Cardiovasc Imaging. 2015;16:210–6.CrossRef
3.
Zurück zum Zitat Flett AS, Hayward MP, Ashworth MT, et al. Equilibrium contrast cardiovascular magnetic resonance for the measurement of diffuse myocardial fibrosis: preliminary validation in humans. Circulation. 2010;122:138–44.CrossRef Flett AS, Hayward MP, Ashworth MT, et al. Equilibrium contrast cardiovascular magnetic resonance for the measurement of diffuse myocardial fibrosis: preliminary validation in humans. Circulation. 2010;122:138–44.CrossRef
4.
Zurück zum Zitat Mascherbauer J, Marzluf BA, Tufaro C, et al. Cardiac magnetic resonance postcontrast T1 time is associated with outcome in patients with heart failure and preserved ejection fraction. Circ Cardiovasc Imaging. 2013;6:1056–65.CrossRef Mascherbauer J, Marzluf BA, Tufaro C, et al. Cardiac magnetic resonance postcontrast T1 time is associated with outcome in patients with heart failure and preserved ejection fraction. Circ Cardiovasc Imaging. 2013;6:1056–65.CrossRef
5.
Zurück zum Zitat Martinez-Naharro A, Treibel TA, Abdel-Gadir A, et al. Magnetic resonance in transthyretin cardiac amyloidosis. J Am Coll Cardiol. 2017;70:466–77.CrossRef Martinez-Naharro A, Treibel TA, Abdel-Gadir A, et al. Magnetic resonance in transthyretin cardiac amyloidosis. J Am Coll Cardiol. 2017;70:466–77.CrossRef
6.
Zurück zum Zitat Sado DM, White SK, Piechnik SK, et al. Identification and assessment of Anderson-Fabry disease by cardiovascular magnetic resonance noncontrast myocardial T1 mapping. Circ Cardiovasc Imaging. 2013;6:392–8.CrossRef Sado DM, White SK, Piechnik SK, et al. Identification and assessment of Anderson-Fabry disease by cardiovascular magnetic resonance noncontrast myocardial T1 mapping. Circ Cardiovasc Imaging. 2013;6:392–8.CrossRef
7.
Zurück zum Zitat Pan JA, Lee YJ, Salerno M. Diagnostic performance of extracellular volume, native T1, and T2 mapping versus lake Louise criteria by cardiac magnetic resonance for detection of acute Myocarditis: a Meta-analysis. Circ Cardiovasc Imaging. 2018;11:e7598.CrossRef Pan JA, Lee YJ, Salerno M. Diagnostic performance of extracellular volume, native T1, and T2 mapping versus lake Louise criteria by cardiac magnetic resonance for detection of acute Myocarditis: a Meta-analysis. Circ Cardiovasc Imaging. 2018;11:e7598.CrossRef
8.
Zurück zum Zitat Puntmann VO, Zeiher AM, Nagel E. T1 and T2 mapping in myocarditis: seeing beyond the horizon of Lake Louise criteria and histopathology. Expert Rev Cardiovasc Ther. 2018;16:319–30.CrossRef Puntmann VO, Zeiher AM, Nagel E. T1 and T2 mapping in myocarditis: seeing beyond the horizon of Lake Louise criteria and histopathology. Expert Rev Cardiovasc Ther. 2018;16:319–30.CrossRef
9.
Zurück zum Zitat Messroghli DR, Moon JC, Ferreira VM, et al. Clinical recommendations for cardiovascular magnetic resonance mapping of T1, T2, T2* and extracellular volume: A consensus statement by the Society for Cardiovascular Magnetic Resonance (SCMR) endorsed by the European Association for Cardiovascular Imaging (EACVI). J Cardiovasc Magn Reson. 2017;19:75.CrossRef Messroghli DR, Moon JC, Ferreira VM, et al. Clinical recommendations for cardiovascular magnetic resonance mapping of T1, T2, T2* and extracellular volume: A consensus statement by the Society for Cardiovascular Magnetic Resonance (SCMR) endorsed by the European Association for Cardiovascular Imaging (EACVI). J Cardiovasc Magn Reson. 2017;19:75.CrossRef
Metadaten
Titel
What is normal? A central question in the application of CMR mapping techniques
verfasst von
Andreas A. Kammerlander, MD, PhD
a.o. Univ. Prof. Dr. Julia Mascherbauer, MD
Publikationsdatum
01.04.2019
Verlag
Springer Vienna
Erschienen in
Wiener klinische Wochenschrift / Ausgabe 7-8/2019
Print ISSN: 0043-5325
Elektronische ISSN: 1613-7671
DOI
https://doi.org/10.1007/s00508-019-1490-9

Weitere Artikel der Ausgabe 7-8/2019

Wiener klinische Wochenschrift 7-8/2019 Zur Ausgabe

MUW researcher of the month

MUW researcher of the month

mitteilungen der gesellschaft der ärzte in wien

Veranstaltungstipps